Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-14 · accession 0001209191-22-061471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-15 | 2022-12-14 | PHIO | Bitterman Robert J | Interim Executive COB, Dir | P - Purchase | $0.39 | +2,000 | 74.5K | +3% | +$780 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2022-12-14 | P | A | 2,000 | $0.39 | 74,541 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |